Osheru Secures $4.7 Million Seed Funding to Advance Revolutionary Ziplyft Device for Blepharoplasty Surgery
23 Julio 2024 - 8:02AM
Business Wire
- Funding to accelerate the development and commercialization of
the company’s groundbreaking device for blepharoplasty surgery
- John Garland Appointed as Chief Commercial Officer
Osheru, a medical device company specializing in innovative
solutions for skin surgery led by Drs. Knute and Patricia Buehler,
announced today the successful completion of a $4.7 million funding
round to accelerate the development and commercialization of its
groundbreaking Ziplyft device for blepharoplasty surgery. The round
was led by individuals and family offices, including investment
from Nike Co-Founder Phil Knight. Additional investors include
Oregon ToughTech BreakThrough Fund managed by ONAMI for Business
Oregon and SOPHINCAP, the Corporate Venture Fund of Laboratorios
Sophia, an international ophthalmology company and leader in
research and innovation. The resulting oversubscribed funding round
reflects robust investor confidence in Osheru’s transformative
approach to eyelid surgery.
"This $4.7 million funding marks a pivotal moment for Osheru,"
said Dr. Patricia Buehler, CEO. "It demonstrates the strong
confidence in Ziplyft from both the medical community and
investors, validating our vision to revolutionize blepharoplasty
with cutting-edge technology."
Osheru also announced the appointment of John Garland as Chief
Commercial Officer. A veteran executive in the ophthalmology
industry, Mr. Garland brings decades of experience in medical
device innovation and commercialization, having managed global
operations in 70 countries with exceptional results. His strategic
leadership and passion for improving the surgeon and patient
experience will be pivotal as Osheru accelerates its
commercialization efforts.
“Joining Osheru to launch Ziplyft is an exciting opportunity,”
said Mr. Garland. “This innovative technology addresses key
challenges in blepharoplasty, promising improved outcomes for
patients and enhanced capabilities for surgeons. I'm eager to drive
its growth and advance the field of eyelid surgery.”
According to the International Society of Aesthetic Plastic
Surgery (ISAPS), there were an estimated 1.7 million eyelid
surgeries performed worldwide in 2023, representing a 24 percent
increase compared to 2022. Blepharoplasty, a procedure aimed at
rejuvenating the appearance of the eyelids, remains one of the most
sought-after cosmetic surgeries in the U.S. particularly with the
increase in video calls and selfies. Traditional methods, unchanged
for decades, have spurred demand for safer, less invasive
alternatives like Ziplyft, positioning Osheru at the forefront of
surgical innovation in this space.
The Ziplyft device is intentionally designed to address
challenges associated with conventional blepharoplasty procedures,
including extended recovery times and risk of complications such as
wound dehiscence and asymmetry. Leveraging Drs. Patricia and Knute
Buehler’s extensive surgical expertise and product development
experience, Ziplyft promises reduced downtime and enhanced
aesthetic outcomes through its proprietary design.
"Despite the challenging fundraising environment for startups
today, Osheru’s success in securing this funding round highlights
their perseverance and the compelling value proposition of
Ziplyft," added Skip Rung, ONAMI President. "We are enthusiastic,
about the potential of the technology to positively impact patient
outcomes."
Patricia Buehler, MD, MPH, renowned eye surgeon and CEO of
Osheru, received acclaim earlier this year when Ziplyft clinched
the prestigious Eyecelerator People’s Choice Award for its
innovative advancements in blepharoplasty techniques. The previous
year she won The Winning Pitch Challenge for best early-stage
company at the American Society of Cataract and Refractive Surgeons
(ASCRS), the largest U.S. society dedicated to anterior segment
surgeons. These accolades underscore Ziplyft’s potential to
revolutionize not only the field of ophthalmology but also
dermatology, plastic surgery, and other areas by offering minimally
invasive alternatives to traditional skin removal procedures.
With commercialization slated for 2025, Osheru is poised to
introduce Ziplyft as a game-changing solution for ophthalmologists,
oculoplastic surgeons, and facial plastic surgeons seeking to
optimize patient outcomes in eyelid surgery as well as other areas
of excess skin removal.
For more information about Osheru and Ziplyft, visit
www.osheru.com.
About Osheru
Osheru is a forward-thinking medical device company specializing
in innovative solutions for skin surgery. Founded by Drs. Patricia
and Knute Buehler, Osheru aims to redefine standards in
blepharoplasty through its revolutionary Ziplyft device, designed
to enhance surgical precision and patient recovery.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240723044165/en/
Alyssa Pineau Osheru 541-419-0135 apineau@osheru.com